Methohexital

What is Methohexital?

Methohexital is a potent, short-acting barbiturate primarily used as a general anaesthetic. Developed in the 1950s, it quickly gained recognition for its rapid onset and relatively quick recovery profile, making it valuable for inducing anesthesia and maintaining it for brief periods, or for providing deep sedation in controlled clinical environments. Its use is typically restricted to hospital settings, administered by trained anaesthesiologists or medical professionals. While newer anaesthetic agents like propofol have become more prevalent, Methohexital still holds a significant place, particularly in specialized procedures such as electroconvulsive therapy (ECT) due to its unique pharmacological properties. Patients receiving Methohexital are closely monitored for vital signs and potential side effects.

How Does it Work?

The primary mechanism of action for Methohexital involves its interaction with the central nervous system (CNS). As a barbiturate, it acts as a positive allosteric modulator of the gamma-aminobutyric acid (GABA) type A receptor. GABA is the principal inhibitory neurotransmitter in the brain, and by enhancing its effects, Methohexital effectively depresses CNS activity. It binds to specific sites on the GABA receptors, increasing the frequency of chloride channel opening. This influx of chloride ions hyperpolarizes the neuronal membrane, making it less excitable and inhibiting neuronal firing. This potentiation of GABAergic inhibition leads to the characteristic sedative-hypnotic, anaesthetic, and anticonvulsant effects of Methohexital. The rapid distribution and metabolism of the drug contribute to its fast onset of action and relatively short duration, allowing for quicker patient recovery.

Medical Uses

Methohexital is primarily indicated for induction of intravenous anaesthesia. Its rapid action makes it suitable for initiating a state of unconsciousness before other anaesthetic agents are administered. Key medical uses include:

• Induction of General Anaesthesia: Quickly brings about unconsciousness for surgical procedures.
• Short Surgical and Diagnostic Procedures: Ideal for brief interventions where rapid onset and recovery are beneficial, such as minor procedures or endoscopic examinations.
• Electroconvulsive Therapy (ECT): Often the preferred anaesthetic agent for ECT due to its rapid, deep, but short-lived anaesthesia, and minimal effect on seizure duration.
• Sedation for Painful Procedures: Used to provide deep sedation for procedures requiring patient stillness.

Its use is carefully weighed against patient-specific factors and the availability of other suitable anaesthetics.

Dosage

The dosage of Methohexital is highly individualized and must be determined by an experienced anaesthesiologist based on the patient's age, weight, overall health, and the specific medical procedure. It is administered intravenously as a solution.

Typical Induction Doses for Adults:

• For general anaesthesia induction, a common dose ranges from 1 to 1.5 mg/kg of body weight, administered intravenously over 30-60 seconds.
• For electroconvulsive therapy (ECT), doses are typically around 0.75 to 1 mg/kg.

Due to its potent effects, Methohexital should always be administered in a setting where resuscitation equipment and trained personnel are immediately available to manage potential complications such as respiratory depression or hypotension. The total dose is carefully titrated to achieve the desired clinical effect while minimizing side effects.

Side Effects

Like all anaesthetic agents, Methohexital can cause a range of side effects. Close monitoring during and after administration is crucial. Common side effects include:

• Respiratory Depression: A significant concern, potentially leading to shallow breathing or temporary cessation of breathing (apnea).
• Cardiovascular Effects: Hypotension (low blood pressure) is common. Tachycardia (increased heart rate) may also occur.
• Involuntary Muscle Movements: Patients may experience muscle twitching, tremors, or hiccups during induction or recovery.
• Pain at Injection Site: Can occur, particularly if administered into smaller veins.
• Nausea and Vomiting: Less common but can occur during recovery.
• Allergic Reactions: Though rare, hypersensitivity reactions are possible.

Contraindications for Methohexital include patients with porphyria, severe cardiovascular or respiratory disease, or known hypersensitivity to barbiturates.

Drug Interactions

Methohexital can interact with several other medications, potentially altering its effects or increasing the risk of adverse reactions. Healthcare providers must have a complete list of all medications a patient is taking.

• Other CNS Depressants: Concurrent use with opioids, benzodiazepines, alcohol, or other sedatives can lead to additive CNS depression, increasing the risk of respiratory depression.
• Neuromuscular Blockers: May potentiate the effects of non-depolarizing neuromuscular blockers, potentially prolonging muscle relaxation.
• Enzyme Inducers/Inhibitors: Drugs that alter hepatic enzymes (e.g., phenobarbital, phenytoin, cimetidine) can affect Methohexital's metabolism, altering its duration and intensity of action.
• Antihypertensives: Concomitant use may exacerbate the hypotensive effects of Methohexital.

Careful consideration and dose adjustments are necessary when Methohexital is used with these or other potentially interacting drugs.

FAQ

Is Methohexital still commonly used today?

While newer agents like propofol have largely replaced Methohexital for general anaesthesia induction in many settings, it remains a valuable option for specific procedures, particularly electroconvulsive therapy (ECT), due to its rapid onset and favorable recovery profile.

How quickly does Methohexital take effect?

Methohexital acts very rapidly. When administered intravenously, unconsciousness is typically achieved within 30 to 60 seconds.

What is the main difference between Methohexital and Thiopental?

Both are barbiturate anaesthetics, but Methohexital generally has a faster onset and a quicker recovery time compared to thiopental. Methohexital also causes less cumulative effect with repeated dosing due to its faster metabolism.

Can Methohexital be used for long-term sedation?

No, Methohexital is not suitable for long-term sedation. Its rapid metabolism and short duration of action make it ideal for induction of anaesthesia or very brief procedures, not for prolonged sedative states.

Products containing Methohexital are available through trusted online pharmacies. You can browse Methohexital-based medications at ShipperVIP or Medicenter.

Summary

Methohexital is a potent, short-acting barbiturate primarily utilized as an intravenous anaesthetic for rapid induction of unconsciousness. Its mechanism involves enhancing the inhibitory effects of GABA in the brain, leading to profound CNS depression. While its use has seen some decline with the advent of newer agents, it remains a preferred choice for specific applications like electroconvulsive therapy due to its fast onset and rapid recovery. As with all powerful anaesthetics, its administration requires careful dosing, continuous patient monitoring, and a thorough understanding of potential side effects and drug interactions to ensure patient safety and optimal outcomes.